Vimentin expressed on Mycobacterium tuberculosis-infected human monocytes is involved in binding to the NKp46 receptor

Journal of Immunology

Volumn 177, Issue 9, 2006, Pages 6192-6198

  Garg, Ankita ^a   Barnes, Peter F ^a   Porgador, Angel ^c   Roy, Sugata ^a   Wu, Shiping ^a   Nanda, Jagpreet S ^a   Griffith, David E ^b   Girard, William M ^b   Rawal, Nenoo ^a   Shetty, Sreerama ^a   Vankayalapati, Ramakrishna ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b Health Science Center   (United States)

^c BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ANTISERUM; HYBRID PROTEIN; LIGAND; MONOCLONAL ANTIBODY; PROTEIN P46; RECEPTOR; RECOMBINANT PROTEIN; VIMENTIN;

ANIMAL CELL; ARTICLE; CELL SURFACE; CONTROLLED STUDY; CYTOLYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE MICROSCOPY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NATURAL KILLER CELL; NONHUMAN; PHAGOCYTE; PHAGOCYTOSIS; PLASMID; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; WESTERN BLOTTING;

EID: 33750305145     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.9.6192     Document Type: Article

References (46)

1. Hamerman, J. A., K. Ogasawara, and L. L. Lanier. 2005. NK cells in innate immunity. Curr. Opin. Immunol. 17: 29-35.
2. Orange, J. S., M. S. Fassett, L. A. Koopman, J. E. Boyson, and J. L. Strominger. 2002. Viral evasion of natural killer cells. Nat. Immunol. 3: 1006-1012.
3. Bukowski, J. F., B. A. Woda, S. Habu, K. Okumura, and R. M. Welsh. 1983. Natural killer cell depletion enhances virus synthesis and virus-induced hepatitis in vivo. J. Immunol. 131: 1531-1538.
4. Ma, L. L., C. L. Wang, G. G. Neely, S. Epelman, A. M. Krensky, and C. H. Mody. 2004. NK cells use perforin rather than granulysin for anticryptococcal activity. J. Immunol. 173: 3357-3365.
5. Korbel, D. S., K. C. Newman, C. R. Almeida, D. M. Davis, and E. M. Riley. 2005. heterogeneous human NK cell responses to Plasmodium falciparum-infected erythrocytes. J. Immunol. 175: 7466-7473.
6. Lanier, L. L. 2001. On guard-activating NK cell receptors. Nat. Immunol. 2: 23-27.
7. Moretta, L., R. Biassoni, C. Bottino, M. C. Mingari, and A. Moretta. 2000. Human NK-cell receptors. Immunol. Today 21: 420-422.
8. Moretta, A., C. Bottino, M. C. Mingari, R. Biassoni, and L. Moretta. 2002. What is a natural killer cell? Nat. Immunol. 3: 6-8.
9. Arase, H., E. S. Mocarski, A. E. Campbell, A. B. Hill, and L. L. Lanier. 2002. Direct recognition of cytomegalovirus by activating and inhibitory NK cell receptors. Science 296: 1323-1326.
10. Mandelboim, O., N. Lieberman, M. Lev, L. Paul, T. I. Arnon, Y. Bushkin, D. M. Davis, J. L. Strominger, J. W. Yewdell, and A. Porgador. 2001. Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells. Nature 409: 1055-1060.
11. Bloushtain, N., U. Qimron, A. Bar-Ilan, O. Hershkovitz, R. Gazit, E. Fima, M. Korc, I. Vlodavsky, N. V. Bovin, and A. Porgador. 2004. Membrane-associated heparan sulfate proteoglycans are involved in the recognition of cellular targets by NKp30 and NKp46. J. Immunol. 173: 2392-2401.
12. Warren, H. S., A. L. Jones, C. Freeman, J. Bettadapura, and C. R. Parish. 2005. Evidence that the cellular ligand for the human NK cell activation receptor NKp30 is not a heparan sulfate glycosaminoglycan. J. Immunol. 175: 207-212.
13. Vankayalapati, R., A. Garg, A. Porgador, D. E. Griffith, P. Klucar, H. Safi, W. M. Girard, D. Cosman, T. Spies, and P. F. Barnes. 2005. Role of NK cell-activating receptors and their ligands in the lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 175: 4611-4617.
14. Vankayalapati, R., B. Wizel, S. E. Weis, H. Safi, D. L. Lakey, O. Mandelboim, B. Samten, A. Porgador, and P. F. Barnes. 2002. The NKp46 receptor contributes to NK cell lysis of mononuclear phagocytes infected with an intracellular bacterium. J. Immunol. 168: 3451-3457.
15. Nieminen, M., T. Henttinen, M. Merinen, F. Marttila-Ichihara, J. E. Eriksson, and S. Jalkanen. 2006. Vimentin function in lymphocyte adhesion and transcellular migration. Nat. Cell Biol. 8: 156-162.
16. Eckes, B., E. Colucci-Guyon, H. Smola, S. Nodder, C. Babinet, T. Krieg, and P. Martin. 2000. Impaired wound healing in embryonic and adult mice lacking vimentin. J. Cell Sci. 113(Pt. 13): 2455-2462.
17. Rius, C., and P. Aller. 1992. Vimentin expression as a late event in the in vitro differentiation of human promonocytic cells. J. Cell Sci. 101(Pt. 2): 395-401.
18. Risco, C., J. R. Rodriguez, C. Lopez-Iglesias, J. L. Carrascosa, M. Esteban, and D. Rodriguez. 2002. Endoplasmic reticulum-Golgi intermediate compartment membranes and vimentin filaments participate in vaccinia virus assembly. J. Virol. 76: 1839-1855.
19. Belin, M. T., and P. Boulanger. 1987. Processing of vimentin occurs during the early stages of adenovirus infection. J. Virol. 61: 2559-2566.
20. Mor-Vaknin, N., A. Punturieri, K. Sitwala, and D. M. Markovitz. 2003. Vimentin is secreted by activated macrophages. Nat. Cell Biol. 5: 59-63.
21. Vankayalapati, R., B. Wizel, B. Samten, D. E. Griffith, H. Shams, M. R. Galland, C. F. Von Reyn, W. M. Girard, R. J. Wallace, Jr., and P. F. Barnes. 2001. Cytokine profiles in immunocompetent persons infected with Mycobacterium avium complex. J. Infect. Dis. 183: 478-484.
22. Zhang, M., J. Gong, Y. Lin, and P. F. Barnes. 1998. Growth of virulent and avirulent Mycobacterium tuberculosis strains in human macrophages. Infect. Immun. 66: 794-799.
23. Wizel, B., M. Palmieri, C. Mendoza, B. Arana, J. Sidney, A. Sette, and R. Tarleton. 1998. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. J. Clin. Invest. 102: 1062-1071.
24. Hansen, C. B., B. van Deurs, L. C. Petersen, and L. V. Rao. 1999. Discordant expression of tissue factor and its activity in polarized epithelial cells: asymmetry in anionic phospholipid availability as a possible explanation. Blood 94: 1657-1664.
25. Rawal, N., and M. K. Pangburn. 1998. C5 convertase of the alternative pathway of complement: kinetic analysis of the free and surface-bound forms of the enzyme. J. Biol. Chem. 273: 16828-16835.
26. Christopherson, R. I. 1983. Desalting protein solutions in a centrifuge column. Methods Enzymol. 91: 278-281.
27. Clarke, E. J., and V. Allan. 2002. Intermediate filaments: vimentin moves in. Curr. Biol. 12: R596-R598.
28. Coulombe, P. A., O. Bousquet, L. Ma, S. Yamada, and D. Wirtz. 2000. The 'ins' and 'outs' of intermediate filament organization. Trends Cell Biol. 10: 420-428.
29. Fuchs, E., and D. W. Cleveland. 1998. A structural scaffolding of intermediate filaments in health and disease. Science 279: 514-519.
30. Xu, B., R. M. deWaal, N. Mor-Vaknin, C. Hibbard, D. M. Markovitz, and M. L. Kahn. 2004. The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature. Mol. Cell Biol. 24: 9198-9206.
31. Perides, G., C. Harter, and P. Traub. 1987. Electrostatic and hydrophobic interactions of the intermediate filament protein vimentin and its amino terminus with lipid bilayers. J. Biol. Chem. 262: 13742-13749.
32. Nishimura, N., and W. E. Balch. 1997. A di-acidic signal required for selective export from the endoplasmic reticulum. Science 277: 556-558.
33. Nishimura, N., S. Bannykh, S. Slabough, J. Matteson, Y. Altschuler, K. Hahn, and W. E. Balch. 1999. A di-acidic (DXE) code directs concentration of cargo during export from the endoplasmic reticulum. J. Biol. Chem. 274: 15937-15946.
34. Liebowitz, D., R. Kopan, E. Fuchs, J. Sample, and E. Kieff. 1987. An Epstein-Barr virus transforming protein associates with vimentin in lymphocytes. Mol. Cell. Biol. 7: 2299-2308.
35. Frank, E. D., and L. Warren. 1981. Aortic smooth muscle cells contain vimentin instead of desmin. Proc. Natl. Acad. Sci. USA 78: 3020-3024.
36. Capco, D. G., K. M. Wan, and S. Penman. 1982. The nuclear matrix: three-dimensional architecture and protein composition. Cell 29: 847-858.
37. Didier, E. S., E. Wheeler, M. S. Rutherford, and W. A. Tompkins. 1988. Characterization of two highly phosphorylated cytoskeleton-associated proteins, pp58 and pp60, in tumoricidal murine peritoneal macrophages and their comparison with vimentin. Mol. Immunol. 25: 785-794.
38. Foster, C. E., M. Colonna, and P. D. Sun. 2003. Crystal structure of the human natural killer (NK) cell activating receptor NKp46 reveals structural relationship to other leukocyte receptor complex immunoreceptors. J. Biol. Chem. 278: 46081-46086.
39. Boyington, J. C., S. A. Motyka, P. Schuck, A. G. Brooks, and P. D. Sun. 2000. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405: 537-543.
40. Fan, Q. R., E. O. Long, and D. C. Wiley. 2001. Crystal structure of the human natural killer cell inhibitory receptor KTR2DL1-HLA-Cw4 complex. Nat. Immunol. 1: 452-460.
41. Barnes, P. F., S. J. Fong, P. J. Brennan, P. E. Twomey, A. Mazumder, and R. L. Modlin. 1990. Local production of tumor necrosis factor and IFN-γ in tuberculous pleuritis. J. Immunol. 145: 149-154.
42. Ciaramella, A., A. Cavone, M. B. Santucci, M. Amicosante, A. Martino, G. Auricchio, L. P. Pucillo, V. Colizzi, and M. Fraziano. 2002. Proinflammatory cytokines in the course of Mycobacterium tuberculosis-induced apoptosis in monocytes/macrophages. J. Infect. Dis. 186: 1277-1282.
43. Giacomini, E., E. Iona, L. Ferroni, M. Miettinen, L. Fattorini, G. Orefici, I. Julkunen, and E. M. Coccia. 2001. Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response. J. Immunol. 166: 7033-7041.
44. Tskvitaria-Fuller, I., A. L. Rozelle, H. L. Yin, and C. Wulfing. 2003. Regulation of sustained actin dynamics by the TCR and costimulation as a mechanism of receptor localization. J. Immunol. 171: 2287-2295.
45. Carey, D. J., and M. S. Todd. 1986. A cytoskeleton-associated plasma membrane heparan sulfate proteoglycan in Schwann cells. J. Biol. Chem. 261: 7518-7525.
46. Zilka, A., G. Landau, O. Hershkovitz, N. Bloushtain, A. Bar-Ilan, F. Benchetrit, E. Fima, T. H. van Kuppevelt, J. T. Gallagher, S. Elgavish, and A. Porgador. 2005. Characterization of the heparin/heparan sulfate binding site of the natural cytotoxicity receptor NKp46. Biochemistry 44: 14477-14485.